Literature DB >> 25356153

MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.

Chun-Jin Xu1, Feng Xu2.   

Abstract

Colorectal cancer is one of the most common types of cancer and has a high mortality rate, making accurate prediction of clinical prognosis an important concern. This study sought to investigate the expression of two proteins, MMP-11 and VEGF-C, in colorectal adenocarcinoma tissues to provide options for better tumor detection. The correlation of the expression of these proteins with the clinical and pathological features of colorectal adenocarcinoma and with the invasion and metastasis of colorectal adenocarcinoma were assessed. Immunohistochemistry with light microscopy was used to detect the expression level of MMP-11 and VEGF-C in 78 samples of colorectal adenocarcinoma tissues and in 20 samples of normal colorectal tissues. Expression of MMP-11 in colorectal adenocarcinoma tissues and normal colorectal tissues was detected in 55.1% and 30.0% of samples, respectively; VEGF-C was detected in 78.2% and 15.0% of samples, respectively. The expression of MMP-11 and VEGF-C in colorectal adenocarcinoma tissues were not related to patient age, sex, or tumor location. However, expression was related to Dukes' staging and lymph node metastasis. Expression of MMP-11 was correlated with distant metastasis from tumors. Lastly, expression of MMP-11 in colorectal adenocarcinoma was positively correlated with VEGF-C. In brief, expression of MMP-11 and VEGF-C in colorectal adenocarcinoma tissues serves as a significant index for evaluating the degree of malignancy, clinical stages, lymph nodes, and distant metastasis of colorectal adenocarcinoma. The detection of both of these proteins may help predict the infiltration, metastasis, and prognosis of colorectal adenocarcinoma, and potentially offers new targets for clinical treatment.

Entities:  

Keywords:  MMP-11; VEGF-C; colorectal adenocarcinoma; immunohistochemistry

Year:  2014        PMID: 25356153      PMCID: PMC4211803     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  17 in total

Review 1.  [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].

Authors:  Magdalena Groblewska; Barbara Mroczko; Maciej Szmitkowski
Journal:  Postepy Hig Med Dosw (Online)       Date:  2010-01-26       Impact factor: 0.270

2.  The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.

Authors:  F-H Han; H-M Li; D-H Zheng; Y-L He; W-H Zhan
Journal:  Eur J Surg Oncol       Date:  2010-12       Impact factor: 4.424

Review 3.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

4.  Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.

Authors:  Xuemei Li; Baoquan Liu; Jianbing Xiao; Ying Yuan; Jing Ma; Yafang Zhang
Journal:  J Gastrointest Surg       Date:  2011-07-23       Impact factor: 3.452

5.  Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.

Authors:  Veli-Matti Wasenius; Samuli Hemmer; Eeva Kettunen; Sakari Knuutila; Kaarle Franssila; Heikki Joensuu
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

6.  Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.

Authors:  Sandra F Martins; Eduardo A Garcia; Marcus Alexandre Mendes Luz; Fernando Pardal; Mesquita Rodrigues; Adhemar Longatto Filho
Journal:  Cancer Genomics Proteomics       Date:  2013 Mar-Apr       Impact factor: 4.069

7.  Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.

Authors:  Zhong-Sheng Zhao; Yong-Quan Chu; Zai-Yuan Ye; Yuan-Yu Wang; Hou-Quan Tao
Journal:  Hum Pathol       Date:  2010-01-08       Impact factor: 3.466

8.  Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development.

Authors:  J Tan; E Buache; F Alpy; E Daguenet; C-L Tomasetto; G-S Ren; M-C Rio
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

9.  Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.

Authors:  S E Duff; M Jeziorska; S Kumar; N Haboubi; D Sherlock; S T O'Dwyer; G C Jayson
Journal:  Colorectal Dis       Date:  2007-11       Impact factor: 3.788

10.  Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.

Authors:  Noemi Eiró; Belen Fernandez-Garcia; Luis O González; Francisco J Vizoso
Journal:  Oncoimmunology       Date:  2013-05-01       Impact factor: 8.110

View more
  2 in total

1.  Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.

Authors:  Gabriela Sofía Gómez-Macías; María Lourdes Garza-Rodríguez; Raquel Garza-Guajardo; Daniela Monsiváis-Ovalle; Jesús Ancer-Rodríguez; Hugo Alberto Barrera-Saldaña; Oralia Barboza-Quintana
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

2.  Assessment of clinical variables as predictive markers in the development and progression of colorectal cancer.

Authors:  Mahmood Rasool; Arif Malik; Sulayman Waquar; Qura Tul Ain; Rabia Rasool; Muhammad Asif; Nisreen Anfinan; Absarul Haque; Hina Alam; Sagheer Ahmed; Mohammad Hamid Hamdard
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.